Intravenous Iron in Patients With Anaemia of Chronic Kidney Disease
The objective of this study is the evaluation of the efficacy and safety of intravenous iron sucrose in anaemic patients with chronic kidney disease not on renal replacement therapy.
[title]Open Randomized Phase IV Study on Intravenous Iron in Anemic Patients With Chronic Kidney Disease. [conditions]
- Chronic Kidney Failure
- Ages Eligible for Study: 18 years and older
- Genders Eligible for Study:
Both
Inclusion Criteria:
- Chronic kidney disease
- Anaemia (Hb 8 - 11.5 g/dl)
- Age above 18 years
- Signed informed consent
Exclusion Criteria:
- Rapid progression of kidney disease
- Need for dialysis
- Uncontrolled hypertension
Roland M Schaefer, MD University Hospital Muenster
Location:
Westphalia University Hospital Muenster
Muenster, Westphalia,
Germany, 48149
Related Articles:
- Stopping anaemia drug better than reducing dose to normalise haemoglobin levels
- Treating anaemia in patients with kidney disease
Article Comments
Rate this article
List News by Medical Area
Current Sponsors
|
Australia’s leading source for trustworthy medical information written by health professionals. Please be aware that we do not give advice on your individual medical condition, Virtual Medical Centre © 2002 - 2012 | Privacy Policy Last updated 24 May 2012 |
||
This site complies with the HONcode standard for trustworthy health information: verify here.
|
For banner advertising![]() |
Website and videos by![]() Web Design Perth |
| ^ Back to Top | ||












